LFTD Partners Inc. (LIFD) stock
LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
LFTD Partners operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
LFTD Partners's operating income for the twelve months ending Mar 31, 2026 was -$3.32M. For fiscal 2025 it was $913.21K. The highest annual figure on record is $9.81M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $913.21K | – |
| FY2024 | Dec 31, 2024 | -$773.46K | -132.1% |
| FY2023 | Dec 31, 2023 | $2.41M | -75.4% |
| FY2022 | Dec 31, 2022 | $9.81M | +26.1% |
| FY2021 | Dec 31, 2021 | $7.78M | – |
| FY2020 | Dec 31, 2020 | -$1.52M | – |
| FY2019 | Dec 31, 2019 | -$1.26M | – |
| FY2018 | Dec 31, 2018 | -$181.57K | – |
| FY2012 | Dec 31, 2012 | -$1.25M | – |
| FY2011 | Dec 31, 2011 | -$208.25K | – |
| FY2010 | Dec 31, 2010 | -$124.09K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$4.57M | – |
| Q4 FY2025 | Dec 31, 2025 | $38.44K | -46.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.31M | – |
| Q2 FY2025 | Jun 30, 2025 | -$109.64K | – |
| Q1 FY2025 | Mar 31, 2025 | -$328.39K | -149.8% |
| Q4 FY2024 | Dec 31, 2024 | $72.32K | -97.0% |
| Q3 FY2024 | Sep 30, 2024 | -$140.70K | – |
| Q4 FY2023 | Dec 31, 2023 | -$517.14K | -172.2% |
| Q3 FY2023 | Sep 30, 2023 | $659.54K | +33.2% |
| Q2 FY2023 | Jun 30, 2023 | $2.37M | -46.4% |
| Q1 FY2023 | Mar 31, 2023 | -$104.88K | -102.5% |
| Q4 FY2022 | Dec 31, 2022 | $716.72K | -77.9% |
| Q3 FY2022 | Sep 30, 2022 | $495.27K | -78.6% |
| Q2 FY2022 | Jun 30, 2022 | $4.43M | +184.4% |
| Q1 FY2022 | Mar 31, 2022 | $4.17M | +531.7% |
| Q4 FY2021 | Dec 31, 2021 | $3.25M | +582.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.32M | +1938.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.56M | – |
| Q1 FY2021 | Mar 31, 2021 | $660.49K | – |
| Q4 FY2020 | Dec 31, 2020 | $475.64K | – |
| Q3 FY2020 | Sep 30, 2020 | $113.72K | – |
| Q2 FY2020 | Jun 30, 2020 | -$349.03K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.76M | – |
| Q4 FY2019 | Dec 31, 2019 | -$160.75K | – |
| Q3 FY2019 | Sep 30, 2019 | -$151.80K | – |
| Q2 FY2019 | Jun 30, 2019 | -$902.44K | – |
| Q1 FY2019 | Mar 31, 2019 | -$47.94K | – |
| Q4 FY2018 | Dec 31, 2018 | -$40.31K | – |
| Q3 FY2018 | Sep 30, 2018 | -$29.79K | – |
| Q2 FY2018 | Jun 30, 2018 | -$91.40K | – |
| Q1 FY2018 | Mar 31, 2018 | -$20.07K | – |
See a number that looks wrong?